We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
“I remain concerned that individuals with potential conflicts of interest are not adequately disclosing those ties to the federal government,” Wyden said. Read More
The EMA’s Pharmacovigilance Risk Assessment Committee is considering recommending more rigorous patient screening before starting treatment with a common family of anti-cancer and topical skin cream drugs. Read More
The FDA issued an updated alert based on a “potentially concerning signal” that the chemotherapy drug paclitaxel on balloons and stents might be contributing to patient deaths. Read More
A bill that would implement a statewide program to track opioids and other prescription drugs has gone over to the Missouri Senate, where previous versions have gone to die. Read More